Tag: Heart / Stroke-Related: Stroke
Circulating Metabolites Linked to Risk for Incident Stroke
10 significant metabolite associations identified, including amino acid histidine, glycolysis-related metabolite pyruvate
AHA: Mavacamten May Treat Hypertrophic Cardiomyopathy
Improvements in cardiac structure, function seen at 30 weeks of treatment with mavacamten versus placebo
Stroke Risk Increased With Depressive Symptoms
Middle-aged and older Black and White adults have increased stroke risk with CES-D-4 scores of 1 to 3, 4 or more
COVID-19-Linked Ischemic Strokes More Severe
More severe disability on discharge and more inpatient death reported for ischemic stroke in COVID-19 patients versus controls
Two-Thirds of U.S. Adults Have Recommended Stroke Knowledge
Considerable difference in stroke knowledge found by race, Hispanic origin, with highest prevalence among non-Hispanic Whites
Major Neurological Disorders on the Rise in the United States
Burden increasing largely due to aging of the U.S. population
Incidence of Cerebrovascular Disease Quantified in COVID-19
1.4 percent of patients with COVID-19 have acute cerebrovascular disease, most often acute ischemic stroke
Many U.S. Young Adults Not Aware of Stroke Symptoms
Weekend Admission Tied to Higher Stroke Mortality
